The phase 2 ASCENT trial assessed the efficacy and safety of afatinib and concurrent chemoradiotherapy with or without surgery in locally advanced epiderma
The Investor Relations website contains information about Intellia Therapeutics’s business for stockholders, potential investors, and financial analysts.
The EMA’s CHMP has issued a positive opinion regarding the use of amivantamab plus lazertinib in select patients with EGFR+ non–small cell lung cancer.
The FDA approved revumenib (Revuforj, Syndax), a menin inhibitor, for relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation in adult…
An abstract is unavailable.
Developed to facilitate a better understanding across the prevention field of needed near-term next steps and long-term future directions to fully realize
Expert cancer information presented in plain language with visuals, charts, and definitions to empower patients and caregivers.
Learn about lung cancer in women, the links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being…
Beyond the physical toll of the disease and its treatments, cancer often presents a host of legal and social issues that can significantly worsen a…
Susan Kaech and Ton Schumacher gave thought-provoking keynotes at the AACR Special Conference: Tumor Immunology and Immunotherapy.
